Patent: 10,519,131
✉ Email this page to a colleague
Summary for Patent: 10,519,131
Title: | Benzazepine compounds, conjugates, and uses thereof |
Abstract: | Benzazepine compounds, conjugates, and pharmaceutical compositions for use in the treatment of disease, such as cancer, are disclosed herein. The disclosed benzazepine compounds are useful, among other things, in the treating of cancer and modulating TLR8. Additionally, benzazepine compounds incorporated into a conjugate with an antibody construct are described herein. |
Inventor(s): | Coburn; Craig Alan (Seattle, WA), Baum; Peter Robert (Seattle, WA), Smith; Sean Wesley (Seattle, WA) |
Assignee: | SILVERBACK THERAPEUTICS, INC. (Seattle, WA) |
Application Number: | 15/973,506 |
Patent Claims: | see list of patent claims |
Details for Patent 10,519,131
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 09/25/1998 | ⤷ Try a Trial | 2037-03-15 |
Genentech, Inc. | HERCEPTIN | trastuzumab | For Injection | 103792 | 02/10/2017 | ⤷ Try a Trial | 2037-03-15 |
Genentech, Inc. | PERJETA | pertuzumab | Injection | 125409 | 06/08/2012 | ⤷ Try a Trial | 2037-03-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |